ether has been researched along with Obesity in 10 studies
Ether: A mobile, very volatile, highly flammable liquid used as an inhalation anesthetic and as a solvent for waxes, fats, oils, perfumes, alkaloids, and gums. It is mildly irritating to skin and mucous membranes.
ether : An organooxygen compound with formula ROR, where R is not hydrogen.
diethyl ether : An ether in which the oxygen atom is linked to two ethyl groups.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We found a fetal sex effect in placental PE and PC ester, ether and plasmalogen PE and PC containing DHA in response to maternal obesity which appears to reflect an ability of female placentas to adapt to maintain optimal fetal DHA transfer in maternal obesity." | 8.31 | Fetal sex differences in placental LCPUFA ether and plasmalogen phosphatidylethanolamine and phosphatidylcholine contents in pregnancies complicated by obesity. ( Berry, KZ; Chassen, SS; Ferchaud-Roucher, V; Jansson, T; Madi, L; Powell, TL; Uhlson, C, 2023) |
| "We found a fetal sex effect in placental PE and PC ester, ether and plasmalogen PE and PC containing DHA in response to maternal obesity which appears to reflect an ability of female placentas to adapt to maintain optimal fetal DHA transfer in maternal obesity." | 4.31 | Fetal sex differences in placental LCPUFA ether and plasmalogen phosphatidylethanolamine and phosphatidylcholine contents in pregnancies complicated by obesity. ( Berry, KZ; Chassen, SS; Ferchaud-Roucher, V; Jansson, T; Madi, L; Powell, TL; Uhlson, C, 2023) |
| "Taken together, the observed lipidome changes in obesity and T2D will facilitate the identification of T2D patient subgroups and represent an important step towards personalized medicine in diabetes." | 4.02 | Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients. ( Brown, SA; Brulhart-Meynet, MC; Chanon, S; David, FPA; Dermitzakis, ET; Dibner, C; Durand, C; Golay, A; Gosselin, P; Guessous, I; Hannich, JT; Harayama, T; Jornayvaz, FR; Lefai, E; Loizides-Mangold, U; Pataky, Z; Paz Montoya, J; Philippe, J; Riezman, H; Robert, M; Saini, C; Sinturel, F; Vandereycken, B, 2021) |
| "On the basis of an analysis of changes in biochemical indices of the hepatic function in 41 patients operated upon for obesity of the 3d or 4th stage the authors make a conclusion that ether narcosis exerts a less injuring effect on the liver as compared with fluothane and is believed to be preferable." | 3.66 | [Functional state of the liver in obese patients subjected to surgery under halothane and ether anesthesia]. ( Borovskikh, NA; Koriukin, VM; Miagkova, LM; Sedletskiĭ, IuI, 1983) |
| "These "overnutrition" diets also promote the accumulation of a variety of harmful lipids in the heart and other peripheral organs, known as lipotoxicity." | 1.72 | Reducing ether lipids improves Drosophila overnutrition-associated pathophysiology phenotypes via a switch from lipid storage to beta-oxidation. ( Alvi, A; Finsel, P; Musselman, LP; O'Toole, A; Santoro, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santoro, C | 1 |
| O'Toole, A | 1 |
| Finsel, P | 1 |
| Alvi, A | 1 |
| Musselman, LP | 1 |
| Powell, TL | 1 |
| Uhlson, C | 1 |
| Madi, L | 1 |
| Berry, KZ | 1 |
| Chassen, SS | 1 |
| Jansson, T | 1 |
| Ferchaud-Roucher, V | 1 |
| Hannich, JT | 1 |
| Loizides-Mangold, U | 1 |
| Sinturel, F | 1 |
| Harayama, T | 1 |
| Vandereycken, B | 1 |
| Saini, C | 1 |
| Gosselin, P | 1 |
| Brulhart-Meynet, MC | 1 |
| Robert, M | 1 |
| Chanon, S | 1 |
| Durand, C | 1 |
| Paz Montoya, J | 1 |
| David, FPA | 1 |
| Guessous, I | 1 |
| Pataky, Z | 1 |
| Golay, A | 1 |
| Jornayvaz, FR | 1 |
| Philippe, J | 1 |
| Dermitzakis, ET | 1 |
| Brown, SA | 1 |
| Lefai, E | 1 |
| Riezman, H | 1 |
| Dibner, C | 1 |
| Sen, P | 1 |
| Hyötyläinen, T | 1 |
| Orešič, M | 1 |
| KARWOWSKA-STAUBEROWA, L | 1 |
| Borovskikh, NA | 2 |
| Koriukin, VM | 1 |
| Sedletskiĭ, IuI | 1 |
| Miagkova, LM | 1 |
| Blair, SC | 1 |
| Caterson, ID | 1 |
| Cooney, GJ | 1 |
| Bukhalo, AE | 1 |
| Karaman, NV | 1 |
| Guillaume-Gentil, C | 1 |
| Rohner-Jeanrenaud, F | 1 |
| Abramo, F | 1 |
| Bestetti, GE | 1 |
| Rossi, GL | 1 |
| Jeanrenaud, B | 1 |
10 other studies available for ether and Obesity
| Article | Year |
|---|---|
Reducing ether lipids improves Drosophila overnutrition-associated pathophysiology phenotypes via a switch from lipid storage to beta-oxidation.
Topics: Animals; Diabetes Mellitus, Type 2; Drosophila; Ether; Lipids; Metabolic Diseases; Obesity; Overnutr | 2022 |
Fetal sex differences in placental LCPUFA ether and plasmalogen phosphatidylethanolamine and phosphatidylcholine contents in pregnancies complicated by obesity.
Topics: Chromatography, Liquid; Ether; Ethers; Ethyl Ethers; Female; Humans; Infant; Male; Obesity; Obesity, | 2023 |
Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Type 2; Ether; Humans; Lipids; Mice; Obesity; Sphingolip | 2021 |
1-Deoxyceramides - Key players in lipotoxicity and progression to type 2 diabetes?
Topics: Diabetes Mellitus, Type 2; Ether; Humans; Lipids; Obesity; Sphingolipids | 2021 |
[HYPOTHALAMO-PITUITARY OBESITY WITH MARKED WATER REGULATION DISORDERS].
Topics: Appendectomy; Ether; Humans; Hypothalamus; Obesity; Pituitary Diseases; Pituitary Gland; Pituitary G | 1963 |
[Functional state of the liver in obese patients subjected to surgery under halothane and ether anesthesia].
Topics: Adult; Anesthesia, Inhalation; Ether; Ethyl Ethers; Halothane; Humans; Ileum; Jejunum; Liver; Liver | 1983 |
Effect of adrenalectomy on glucose tolerance and lipid metabolism in gold-thioglucose obese mice.
Topics: Adrenalectomy; Animals; Aurothioglucose; Blood Glucose; Body Weight; Corticosterone; Eating; Ether; | 1994 |
[Effect of different types of anesthesia on hemodynamics and certain indicators of metabolism in obesity].
Topics: Adult; Aged; Anesthesia; Anesthesia, Endotracheal; Anesthesia, Local; Blood Glucose; Ether; Female; | 1975 |
Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat.
Topics: Animals; Circadian Rhythm; Cold Temperature; Corticosterone; Dexamethasone; Ether; Female; Hypothala | 1990 |
[Changes in cardiohemodynamics in obese patients in response to fluothane, ether and neuroleptanalgesia].
Topics: Abdomen; Adult; Depression, Chemical; Ether; Ethyl Ethers; Halothane; Hemodynamics; Humans; Myocardi | 1987 |